Elucidating the precise pharmacological mechanism of action (MOA) of Obviously developing compounds may be demanding. Whilst Tarselli et al. (60) formulated the main de novo artificial pathway to conolidine and showcased this Normally occurring compound successfully suppresses responses to each chemically induced and inflammation-derived pain, the